DIPROSALIC OINTMENT

Country: Singapura

Bahasa: Inggeris

Sumber: HSA (Health Sciences Authority)

Beli sekarang

Risalah maklumat Risalah maklumat (PIL)
18-02-2013

Bahan aktif:

BETAMETHASONE DIPROPIONATE 0.64MG/G EQV BETAMETHASONE

Boleh didapati daripada:

MSD PHARMA (SINGAPORE) PTE. LTD.

Kod ATC:

D07XC01

Dos:

0.50 mg/g

Borang farmaseutikal:

OINTMENT

Laluan pentadbiran:

TOPICAL

Jenis preskripsi:

Prescription Only

Dikeluarkan oleh:

S-P CANADA

Tarikh kebenaran:

1990-04-20

Risalah maklumat

                                DIPROSALIC® OINTMENT 
Brand of betamethasone dipropionate and salicylic acid 
 
FOR DERMATOLOGIC USE ONLY 
 
DESCRIPTION: DIPROSALIC Ointment provides in each gram 0.64
mg of betamethasone 
dipropionate, equivalent to 0.5 mg (0.05%) of betamethasone, and
30 mg (3%) of salicylic acid. 
Salicylic acid is a keratolytic and antiseptic agent. 
 
ACTIONS: Betamethasone dipropionate, a synthetic fluorinated corticosteroid, has anti-
inflammatory, antipruritic and
vasoconstrictive actions. DIPROSALIC Ointment demonstrates these 
actions in a sustained
manner thereby permitting twice a day application. 
 
Topical salicylic acid has keratolytic properties as well as
bacteriostatic and fungicidal actions. 
 
INDICATIONS AND USAGE: DIPROSALIC Ointment
is indicated for the relief of the inflammatory 
manifestations of hyperkeratotic and
dry corticosteroidresponsive dermatoses such as: psoriasis, 
chronic atopic dermatitis, neurodermatitis
(lichen simplex chronicus), lichen planus, eczema 
(including nummular eczema, hand eczema, eczematous dermatitis),
dyshidrosis (pompholyx), 
seborrheic dermatitis of the scalp, ichthyosis vulgaris and
other ichthyotic conditions. 
 
DOSAGE AND
ADMINISTRATION: A thin film of DIPROSALIC Ointment should
be applied to 
cover completely the affected area, twice daily,
in the morning and at night. For some patients, 
adequate maintenance therapy may be achieved with less
frequent application. 
 
ADVERSE REACTIONS: Adverse reactions that have been reported with
the use of topical 
corticosteroids include: burning, itching, irritation, dryness,
folliculitis, hypertrichosis, acneiform 
eruptions, hypopigmentation, perioral dermatitis, allergic
contact dermatitis. 
 
The following may occur more frequently with the use of occlusive dressings: maceration of the skin, 
secondary infection, skin atrophy, striae and mil
                                
                                Baca dokumen lengkap